Certified by Founder Lodge
Superluminal Medicines Inc.
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $33,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2023 | Seed | $33,000,000 |
RA Capital Management, L.P.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Navier AI | $6,500,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
